NAD+ IV Drips: What The Science Says About Cellular Energy And Aging
A clear-eyed look at what NAD+ does inside cells, what trials have tested, and whether topping it up helps healthy adults.
NAD+ infusions are sold as a fix for aging and low energy, yet the best human data come from oral precursors, and reviewers say the intravenous evidence lags well behind.
Takeaways
Oral NAD+ precursors reliably raise blood NAD+
IV delivery guarantees full bioavailability and rapid, predictable levels
Raising NAD+ hasn't proven clinical benefit yet
Compounded infusions carry contamination and endotoxin risks
Ask who makes the product and why
The Old Standard: Food And Pills Versus A Direct Line To The Bloodstream
For decades, raising your body's supply of vitamin B3 was simple. You ate it, or you took a supplement. Your gut absorbed some of it, your liver processed it, and your cells took what they needed. Intravenous (IV) NAD+ therapy skips that route. A clinician places a line in a vein and drips the molecule straight into the blood over an hour or more.
Route Comparison
Feature | Oral Absorption (Enteral) | Direct Delivery (Parenteral / IV) |
Primary Anatomical Pathway | Mouth -> Stomach -> Small Intestine -> Liver (Portal Vein) -> Systemic Circulation | Direct injection into a peripheral or central vein -> Immediate Systemic Circulation |
Speed of Onset | Delayed: Typically takes 30 to 90 minutes to reach measurable plasma concentrations as the drug must dissolve and pass through GI membranes. | Instantaneous: Reaches the brain and target tissues within seconds to minutes, making it ideal for acute emergencies. |
Bioavailability | Variable and Reduced (<100%): Significantly diminished by low stomach pH, digestive enzymes, and incomplete intestinal absorption. | Complete (100%): The entire administered dose enters circulation immediately without initial structural loss. |
The Liver Barrier | Subject to First-Pass Metabolism: Absorbed compounds travel straight to the liver via the portal system, where enzymes break down a portion of the active drug before it reaches the body. | Bypasses First-Pass Metabolism: Circumvents the liver initially, protecting sensitive molecular structures from early hepatic degradation. |
The pitch is easy to follow. If a nutrient bypasses digestion, more of it should reach your tissues. That sounds logical. It isn't automatically true.
Old standard: Oral B3 forms, absorbed through the gut and processed before reaching cells.
New approach: Infusions of NAD+ itself, or of nicotinamide riboside (NR, a form of vitamin B3 the body converts into NAD+), delivered directly into the bloodstream.
Old standard: Judged by decades of nutrition research and a long safety record.
New approach: Sold mostly in wellness settings, with a much shorter research history.
The Science: Why Cells Need NAD+ And What Happens To It
NAD+ stands for nicotinamide adenine dinucleotide. It's a coenzyme, a helper molecule that lets enzymes do their work. Cells use it to turn food into usable energy inside mitochondria (the small structures that produce most of a cell's fuel), and to carry out DNA repair. The science of its role is sound.
The aging claim is where things get complicated. Researchers have proposed that NAD+ availability falls over a lifetime and may contribute to age-related disease, but a major endocrinology review described the field as full of potential applications and many unknowns (Bhasin et al., 2023). Mouse studies look encouraging. Human data are far less settled.
Here's what we do know. In healthy middle-aged and older adults, taking 1,000 milligrams of oral NR daily raised NAD+ in the blood, and people tolerated it well (Martens et al., 2018). That's a real biochemical effect. It isn't the same as a health benefit.
An Expert's Perspective: Promise And Prudence
Niagen is the trade name of a patented form of NR. Most of the human research on it involves oral doses. Intravenous NR is newer, and published human data on it are sparser still. Two 2026 reviews give the clearest picture so far.
Raising NAD+ is not the same as improving health. A systematic review of 80 animal studies and 33 human trials found that NAD+ supplementation changes biochemistry, but evidence for clinically relevant anti-aging effects in people remains inconclusive (Gallagher & Emmanuel, 2026).
NAD+ supplementation can produce measurable biological changes. Human studies show that NAD+-boosting approaches can increase circulating NAD+ or related metabolites. This establishes biological activity and gives researchers a measurable starting point, although it does not establish better health or slower aging.
Injected NAD+ has almost no evidence from controlled trials. That same review found no eligible controlled trials of injected NAD+ for anti-aging or wellness outcomes. The authors also point out that NAD+ is a large molecule that probably doesn't enter cells intact, so any benefit would likely come from its breakdown products.
The field itself notes that the evidence is preliminary. A 2026 narrative review concluded that current evidence on IV NAD+ and IV precursors is insufficient to support routine clinical or wellness use (Alangari et al., 2026).
Product quality is a real risk. The FDA has warned that some compounders used food-grade NAD+, which isn't made for injection, to prepare IV products. The agency received adverse event reports of severe chills, shaking, vomiting, and fatigue consistent with endotoxins (FDA, 2024). Endotoxins are fragments of bacterial cell walls that can trigger fever and a strong immune reaction when they reach the blood.
Early studies offer signals worth investigating. Small human studies have reported changes in markers related to inflammation, oxidative stress, and metabolism after NAD+ administration. These preliminary findings support larger, placebo-controlled trials, but they do not yet show lasting clinical benefits or justify routine IV wellness use.
Any IV service should operate under licensed medical supervision and clearly state where the product comes from. Compounded means a pharmacy mixed it to order rather than a manufacturer producing it under standard drug approval. Quality varies. Ask which pharmacy made it, and what testing was done.
Claims Versus Evidence At A Glance
Claim | What The Evidence Shows |
Raises NAD+ levels | Supported for oral NR in healthy adults. Not well established for infusions. |
Boosts cellular energy | Plausible biochemistry, but no clear proof of a noticeable effect in healthy people. |
Slows or reverses aging | Not demonstrated in humans. Reviews call the evidence inconclusive. |
Improves cognition or fatigue | Mixed and mostly oral trials in specific patient groups. |
Safe for routine use | Short-term oral NR is well tolerated. IV safety data are limited, and contamination is a documented concern. |
The Road Ahead
For now, NAD+ infusions are promising, not proven. Encouragingly, NAD+-boosting approaches can produce measurable biological changes, and early findings give researchers a reason to keep investigating. Neither establishes that infusions improve health or slow aging, but both support continued study. Real biology sits behind the interest; sourcing, supervision, and evidence matter more than marketing.
What's likely next: The next step is to turn that biological promise into answers patients can use: Do infusions deliver noticeable, lasting benefits, and do they offer any advantage over oral precursors? More rigorous trials could clarify those questions while establishing appropriate doses, infusion rates, and the long-term effects of repeated use. Clearer product-quality standards and better guidance on who should avoid treatment would also help distinguish responsible research from premature wellness claims. |
FAQs
NAD+ the same as nicotinamide riboside?
No. NAD+ is the active coenzyme itself. NR is a precursor, a raw ingredient the body converts into NAD+.
How long does an IV session usually take?
Sessions commonly run one to two hours, with the drip rate adjusted to how the person feels.
What side effects do people report during infusions?
People commonly report nausea, chest tightness, cramping, and flushing, and these often ease when the drip rate slows.
Can you raise NAD+ without an IV?
Yes. Oral NR and NMN raise blood NAD+ in trials, and regular exercise and adequate sleep also support the body's own NAD+ metabolism.
Who should check with a doctor first?
Anyone with heart, kidney, or liver disease, anyone who is pregnant or nursing, and anyone taking prescription medication.
Coming up in the series: cryotherapy and how it differs from a cold plunge, infrared sauna on its own, compression therapy for circulation, LED light therapy for skin and tissue repair, examined with the same mix of research and caution.
Note: Background on recovery-modality offerings referenced for context: Pause Studio — float service descriptions used to ground the practical framing of this article.
Sources
Alangari, A., Arif, J., Al Qureshah, F., & Alkhodairy, F. (2026). Narrative review of intravenous NAD+ and NAD+ precursors in wellness and translational medicine. Frontiers in Aging. https://doi.org/10.3389/fragi.2026.1887175
Bhasin, S., Seals, D., Migaud, M., Musi, N., & Baur, J. A. (2023). Nicotinamide adenine dinucleotide in aging biology: Potential applications and many unknowns. Endocrine Reviews. https://doi.org/10.1210/endrev/bnad019
Gallagher, C., & Emmanuel, O. O. (2026). NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Research Reviews, 116, 103057. https://doi.org/10.1016/j.arr.2026.103057
Martens, C. R., Denman, B. A., Mazzo, M. R., Armstrong, M. L., Reisdorph, N., McQueen, M. B., Chonchol, M., & Seals, D. R. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications, 9, Article 1286. https://doi.org/10.1038/s41467-018-03421-7
U.S. Food and Drug Administration. (2024). FDA reminds compounders to use ingredients suitable for sterile compounding. https://www.fda.gov/drugs/human-drug-compounding/fda-reminds-compounders-use-ingredients-suitable-sterile-compounding
Source Note
Service context drawn from Pause Studio. All clinical and regulatory claims are sourced from the peer-reviewed reviews, trial, and FDA notice cited above, prioritizing 2026 publications.
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider before making health decisions, using wearable devices, or sharing personal medical data.
About the Author
 | David Priede, MIS, PhD, is a healthcare professional and neuroscientist at BioLife Health. He is dedicated to driving progress and encouraging innovation. With a diverse background in business, science, technology, healthcare, and education, David challenges conventional boundaries and develops transformative solutions to key challenges across these interconnected fields. |
Minds In Motion: High-Performance Training for an Age of Distraction
Minds in Motion goes beyond typical fitness books. It is a complete guide for anyone struggling to stay strong, focused, and resilient in a world of chronic stress and relentless distraction.
Authored by Dr. David Priede, PhD, with co-authors Lizbeth Kuruvilla and Cindy Hamilton, this book bridges cutting-edge brain science and practical, sustainable training.
Explore the architecture of human performance by integrating insights from neuroscience, psychology, sleep medicine, and behavioral science. It shows how mindful strength training reshapes the brain through neuroplasticity, how intentional breathwork calms the nervous system, and how sleep, nutrition, and recovery work together to build resilience in a fast-paced life.
